Insurance

Why Do Health Payers Prefer Buying Over Building AI?
Management & Administration Why Do Health Payers Prefer Buying Over Building AI?

The Strategic Shift Toward Vendor-Led AI Adoption The rapid evolution of machine learning has forced healthcare payers into a high-stakes race where the decision to acquire external technology now defines market survival more than internal innovation. Recent data indicates that nearly 80% of health

Can Humana Sustain Growth Under Medicare Cost Pressures?
Management & Administration Can Humana Sustain Growth Under Medicare Cost Pressures?

The recent surge in Humana’s market valuation highlights a significant turning point for a healthcare industry grappling with the intricate complexities of government-backed insurance models and rising medical expenditures. As the landscape of managed care undergoes a profound transformation,

AI and Strategic Partnerships Reshape UK Private Healthcare
Management & Administration AI and Strategic Partnerships Reshape UK Private Healthcare

The landscape of British healthcare has shifted dramatically as the private sector moves from being a secondary option to a central pillar of the nation's medical infrastructure. For many families and businesses, private medical insurance is no longer viewed as a luxury corporate perk but has

Should Food Be a Primary Health Benefit in Medicare?
Management & Administration Should Food Be a Primary Health Benefit in Medicare?

Healthcare policy experts and industry leaders are now advocating for a fundamental transformation in how the Centers for Medicare and Medicaid Services (CMS) perceives the relationship between nutrition and medical insurance. Instead of viewing food assistance as a reactive social service reserved

Can Persona-Based Benefits Close the Employee Health Gap?
Management & Administration Can Persona-Based Benefits Close the Employee Health Gap?

The modern workplace is currently weathering a silent crisis as the sharp escalation of medical expenses fundamentally reshapes the financial stability of the average household. Recent data from industry leaders reveals that over seventy percent of the workforce has grappled with a significant

Is JRNYS Wellness Still a Good Option for GLP-1 Treatment?
Management & Administration Is JRNYS Wellness Still a Good Option for GLP-1 Treatment?

The landscape for metabolic health and weight management has undergone a profound transformation as the market moves through the current 2026 calendar year. While the initial surge of interest in glucagon-peptide-1 receptor agonists was characterized by widespread shortages and supply chain

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later